v3.26.1
Consolidated Statements of Operations - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Revenues:        
Rental income $ 3,684,044 $ 4,032,429 $ 16,470,918 $ 18,523,813
Fees and other income 88,756 92,755 343,790 401,462
Total revenue 3,772,800 4,125,184 16,814,708 18,925,275
Costs and expenses:        
Rental operating costs 1,544,441 1,612,642 6,158,052 6,256,077
General and administrative 1,673,823 1,661,978 5,704,830 7,526,675
Depreciation and amortization 998,969 1,244,104 4,862,267 5,515,518
Impairment of goodwill and real estate assets 524,373 26,943 6,443,437 1,969,311
Total costs and expenses 4,741,606 4,545,667 23,168,586 21,267,581
Other income (expense):        
Interest expense - mortgage notes (2,050,074) (1,510,470) (6,050,437) (6,050,196)
Net loss in Conduit Pharmaceuticals marketable securities (see footnote 9) 1,985 (176,658) (188,287) (17,925,723)
Interest and other income, net 5,149 5,149 20,881 (151,356)
Gain on sales of real estate, net 172,096 4,453,968 5,444,792 3,426,572
Gain on disposition of assets and liabilities, net 3,416,501    
Income tax (expense) benefit (18,057) 25,409 (463,170) (60,855)
Total loss, net 1,527,600 2,797,398 (1,236,221) (20,761,558)
Net loss: 558,794 2,376,915 (7,590,099) (23,103,864)
Less: Income attributable to noncontrolling interests (117,885) (111,563) (685,586) (2,524,665)
Net loss attributable to Presidio Property Trust, Inc. stockholders 440,909 2,265,352 (8,275,685) (25,628,529)
Less: Preferred Stock Series D dividends (579,575) (2,295,607) (2,236,696)
Less: Series D Preferred Stock undeclared dividends in arrears (570,541)    
Net loss attributable to Presidio Property Trust, Inc. common stockholders $ (129,632) $ 1,685,777 $ (10,571,292) $ (27,865,225)
Net loss per share attributable to Presidio Property Trust, Inc. common stockholders:        
Basic $ (0.10) $ 1.31 $ (8.65) $ (22.50)
Diluted $ (0.10) $ 1.31 $ (8.65) $ (22.50)
Weighted average number of common shares outstanding - basic 1,314,159 1,283,432 1,221,413 1,238,659
Weighted average number of common shares outstanding - diluted 1,314,159 1,283,432 1,221,413 1,238,659